These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 26155852)
1. Aortic Dissection as a Possible Underlying Cause of Acute Ischemic Stroke. Kamouchi M Circ J; 2015; 79(8):1697-8. PubMed ID: 26155852 [No Abstract] [Full Text] [Related]
2. Impact of Elevated D-Dimer on Diagnosis of Acute Aortic Dissection With Isolated Neurological Symptoms in Ischemic Stroke. Yoshimuta T; Yokoyama H; Okajima T; Tanaka H; Toyoda K; Nagatsuka K; Higashi M; Hayashi K; Kawashiri MA; Yasuda S; Yamagishi M Circ J; 2015; 79(8):1841-5. PubMed ID: 25993997 [TBL] [Abstract][Full Text] [Related]
3. Cocktail blood biomarkers: prediction of clinical outcomes in patients with acute ischemic stroke. Zeng L; Liu J; Wang Y; Wang L; Weng S; Chen S; Yang GY Eur Neurol; 2013; 69(2):68-75. PubMed ID: 23154383 [TBL] [Abstract][Full Text] [Related]
4. Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer. Kono T; Ohtsuki T; Hosomi N; Takeda I; Aoki S; Sueda Y; Ishihara K; Nakamura T; Yamawaki T; Matsumoto M Geriatr Gerontol Int; 2012 Jul; 12(3):468-74. PubMed ID: 22233138 [TBL] [Abstract][Full Text] [Related]
5. Plasma d-Dimer and Incident Ischemic Stroke and Coronary Heart Disease: The Atherosclerosis Risk in Communities Study. Folsom AR; Gottesman RF; Appiah D; Shahar E; Mosley TH Stroke; 2016 Jan; 47(1):18-23. PubMed ID: 26556822 [TBL] [Abstract][Full Text] [Related]
6. A biomarker panel: an additional resource in acute stroke evaluation? Kimura T; Nishikawa T Minerva Anestesiol; 2013 Jul; 79(7):711-2. PubMed ID: 23558768 [No Abstract] [Full Text] [Related]
7. Antithrombin III associated with fibrinogen predicts the risk of cerebral ischemic stroke. Meng R; Li ZY; Ji X; Ding Y; Meng S; Wang X Clin Neurol Neurosurg; 2011 Jun; 113(5):380-6. PubMed ID: 21316837 [TBL] [Abstract][Full Text] [Related]
8. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin. Yamamoto R; Nakae Y; Tanaka F; Johkura K J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270 [TBL] [Abstract][Full Text] [Related]
10. S100β Protein as a Predictor of Poststroke Functional Outcome: A Prospective Study. Branco JP; Oliveira S; Sargento-Freitas J; Santos Costa J; Cordeiro G; Cunha L; Freire Gonçalves A; Pinheiro J J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1890-1896. PubMed ID: 29571758 [TBL] [Abstract][Full Text] [Related]
11. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Montaner J; Perea-Gainza M; Delgado P; Ribó M; Chacón P; Rosell A; Quintana M; Palacios ME; Molina CA; Alvarez-Sabín J Stroke; 2008 Aug; 39(8):2280-7. PubMed ID: 18535284 [TBL] [Abstract][Full Text] [Related]
12. Blood Biomarkers for the Early Diagnosis of Stroke: The Stroke-Chip Study. Bustamante A; López-Cancio E; Pich S; Penalba A; Giralt D; García-Berrocoso T; Ferrer-Costa C; Gasull T; Hernández-Pérez M; Millan M; Rubiera M; Cardona P; Cano L; Quesada H; Terceño M; Silva Y; Castellanos M; Garces M; Reverté S; Ustrell X; Marés R; Baiges JJ; Serena J; Rubio F; Salas E; Dávalos A; Montaner J Stroke; 2017 Sep; 48(9):2419-2425. PubMed ID: 28716979 [TBL] [Abstract][Full Text] [Related]
13. Plasma thrombin-cleaved osteopontin as a potential biomarker of acute atherothrombotic ischemic stroke. Ozaki S; Kurata M; Kumon Y; Matsumoto S; Tagawa M; Watanabe H; Ohue S; Higaki J; Ohnishi T Hypertens Res; 2017 Jan; 40(1):61-66. PubMed ID: 27558929 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Serum D-Dimer in Noncardioembolic Ischemic Stroke. Kim TW; Song IU; Chung SW Can J Neurol Sci; 2017 Jul; 44(4):404-409. PubMed ID: 27677545 [TBL] [Abstract][Full Text] [Related]
15. D-dimer levels and stroke progression in patients with acute ischemic stroke and atrial fibrillation. Krarup LH; Sandset EC; Sandset PM; Berge E Acta Neurol Scand; 2011 Jul; 124(1):40-4. PubMed ID: 20726843 [TBL] [Abstract][Full Text] [Related]
16. [Hemostatic and fibrinolysis markers in the early phase of acute ischaemic stroke]. Soroka-Wojtaszko M; Dmoszyńska A; Słoma-Madej K; Grzaśko N Pol Arch Med Wewn; 2004 Nov; 112(5):1303-9. PubMed ID: 15773512 [TBL] [Abstract][Full Text] [Related]
17. Should neurologists measure D-dimer concentrations? de Moerloose P; Boehlen F Lancet Neurol; 2003 Feb; 2(2):77. PubMed ID: 12849262 [No Abstract] [Full Text] [Related]
18. Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke. Alvarez-Perez FJ; Castelo-Branco M; Alvarez-Sabin J J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):986-92. PubMed ID: 21296900 [TBL] [Abstract][Full Text] [Related]
19. Clinical severity of ischemic stroke and neural damage biomarkers in the acute setting: the STROke MArkers (STROMA) study. Barbieri A; Giuliani E; Carone C; Pederzoli F; Mascheroni G; Greco G; Stucchi C; Genedani S Minerva Anestesiol; 2013 Jul; 79(7):750-7. PubMed ID: 23511364 [TBL] [Abstract][Full Text] [Related]
20. The role of hs-CRP, D-dimer and fibrinogen in differentiating etiological subtypes of ischemic stroke. Liu LB; Li M; Zhuo WY; Zhang YS; Xu AD PLoS One; 2015; 10(2):e0118301. PubMed ID: 25680111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]